WHO ICTRP trial
Investigation of beta-cell function by receiving semaglutide among inpatints…
JPRN-UMIN000042478 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000042478 |
|---|---|
| Public title | Investigation of beta-cell function by receiving semaglutide among inpatints with type 2 diabetes. |
| Scientific title | Investigation of beta-cell function by receiving semaglutide among inpatints with type 2 diabetes. - Investigation of beta-cell function by receiving semaglutide among inpatints with type 2 diabetes. |
| Primary sponsor | Saiseikai Yokohamashi Nanbu Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | type2 diabetes |
| Interventions | Semaglutide group: In hospitalization, participants inject semaglutide 0.25mg once a week. After discharge, participants inject semaglutide 0.50mg once a week in 12 weeks. Control group: Paticipants does not inject semaglutide until 12… |
| Registration date | Nov 18, 2020 |
| Target size | 80 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: